Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Presumptive tuberculosis treatment to prevent early mortality in advanced HIV starting ART
PACTR201110000301425Recruiting
- Sponsor
- Amsterdam University Medical Center
- Start
- Jul 2011
- Countries
- 4
01
Overview
Open-label trial in human immunodeficiency virus infection (HIV) and Tuberculosis (TB) (2 arms), sponsored by Amsterdam University Medical Center. Primary endpoint: All-cause mortality. Started Jul 2011; status: recruiting.
02
Conditions
human immunodeficiency virus infection (HIV)Tuberculosis (TB)
Beyond the preview
Go deeper on PACTR201110000301425.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on PACTR201110000301425.